Is BIOL or EQR a better dividend investment in 2026?

BIOL currently yields 10000.00% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: BIOL offers higher current income.

What is the dividend yield difference between BIOL and EQR?

BIOL has a forward dividend yield of 10000.00% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 9995.27 percentage points.

Home › Compare › BIOL vs EQR

BIOL vs EQR: Dividend Comparison 2026

BIOL yields 10000.00% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BIOL wins by $55137509079256512.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BIOL

● Live price

10000.00%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$55137509079256512.00M

Annual income

$54,073,795,673,722,890,000,000.00

Full BIOL calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — BIOL vs EQR

📍 BIOL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BIOL	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BIOL + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BIOL pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOL

Annual income on $10K today (after 15% tax)

$850,000.00/yr

After 10yr DRIP, annual income (after tax)

$45,962,726,322,664,450,000,000.00/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, BIOL beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOL + EQR for your $10,000?

BIOL: 50%EQR: 50%

100% EQR50/50100% BIOL

Portfolio after 10yr

$27568754539628256.00M

Annual income

$27,036,897,836,861,443,000,000.00/yr

Blended yield

98.07%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BIOL

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-17.2

Piotroski

4/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOL buys

EQR buys

No recent congressional trades found for BIOL or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBIOLEQR

Forward yield	10000.00% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$55137509079256512.00M ✓	$40.5K
Annual income after 10y	$54,073,795,673,722,890,000,000.00 ✓	$3,819.61
Total dividends collected	$55066727460582336.00M ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: BIOL vs EQR ($10,000, DRIP)

Year	BIOL Portfolio	BIOL Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$1,010,700	$1,000,000.00	$11,248	$547.57	+$999.5K → BIOL
2	$95,539,393	$94,457,943.93	$12,701	$666.53	+$95.53M → BIOL
3	$8,447,007,736	$8,344,780,585.66	$14,405	$814.59	+$8446.99M → BIOL
4	$698,565,746,383	$689,527,448,105.17	$16,413	$999.84	+$698565.73M → BIOL
5	$54,040,711,670,213	$53,293,246,321,583.74	$18,795	$1,232.92	+$54040711.65M → BIOL
6	$3,910,851,616,519,516	$3,853,028,055,032,387.00	$21,639	$1,527.95	+$3910851616.50M → BIOL
7	$264,781,167,546,477,440	$260,596,556,316,801,570.00	$25,057	$1,903.80	+$264781167546.45M → BIOL
8	$16,772,556,223,821,672,000	$16,489,240,374,546,942,000.00	$29,197	$2,385.87	+$16772556223821.64M → BIOL
9	$994,124,678,068,810,000,000	$976,178,042,909,320,800,000.00	$34,250	$3,008.70	+$994124678068810.00M → BIOL
10	$55,137,509,079,256,515,000,000	$54,073,795,673,722,890,000,000.00	$40,467	$3,819.61	+$55137509079256512.00M → BIOL

BIOL vs EQR: Complete Analysis 2026

BIOL — Stock

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Full BIOL Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this BIOL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOL vs SCHD BIOL vs JEPI BIOL vs O BIOL vs KO BIOL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.